ArticleScience and technology of advanced materials2015
Synthesis of nanoparticle CT contrast agents:
Article in Science and technology of advanced materials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 25 citations in OpenAlex.
- An in silico evaluation of signal and separability properties of k-edge materials in spectral CT.Scientific reports · 2026Article
- Monolacunary Wells-Dawson Polyoxometalate as a Novel Contrast Agent for Computed Tomography: A Comprehensive Study on In Vivo Toxicity and Biodistribution.International journal of molecular sciences · 2024Article
- Ultrasmall cerium oxide nanoparticles as highly sensitive X-ray contrast agents and their antioxidant effect.RSC advances · 2024Article
- Heavy Metal-Based Nanoparticles as High-Performance X-ray Computed Tomography Contrast Agents.Pharmaceuticals (Basel, Switzerland) · 2023Review
- In vivo toxicity evaluation of a polyoxotungstate nanocluster as a promising contrast agent for computed tomography.Scientific reports · 2023Article
- Click functionalized biocompatible gadolinium oxide core-shell nanocarriers for imaging of breast cancer cells.RSC advances · 2022Article
- Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications.Nanomaterials (Basel, Switzerland) · 2021Review
- Synthesis, Characterizations, and 9.4 Tesla TNanomaterials (Basel, Switzerland) · 2021Article
- In Vivo Tracking of Tissue Engineered Constructs.Micromachines · 2019Review
- Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging.Scientific reports · 2018Article
- Multimodal Molecular Imaging: Current Status and Future Directions.Contrast media & molecular imaging · 2018Review
- Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.Advanced drug delivery reviews · 2017Review
- Cytocompatible and multifunctional polymeric nanoparticles for transportation of bioactive molecules into and within cells.Science and technology of advanced materials · 2016Article
- Improved Calcium Scoring at Dual-Energy Computed Tomography Angiography Using a High-Z Contrast Element and Novel Material Separation Technique.Journal of computer assisted tomographyArticle
- Advances in nanotechnology-based targeted-contrast agents for computed tomography and magnetic resonance.Science progressReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Water-soluble and biocompatible D-glucuronic acid coated Na
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.